home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

57 rows where docket_id = "FDA-2007-D-0369" and posted_year = 2021 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, comment_end_date, last_modified, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 2

  • Other 49
  • Notice 8

posted_year 1

  • 2021 · 57 ✖

agency_id 1

  • FDA 57
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2007-D-0369-0585 FDA None FDA-2007-D-0369 Draft Guidance on Alprazolam; Revised Guidance; PSG_021726 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:34Z   1 0 0900006484e387f6
FDA-2007-D-0369-0586 FDA None FDA-2007-D-0369 Draft Guidance on Colesevelam Hydrochloride; Revised Guidance; PSG_021176 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:34Z   1 0 0900006484e387f8
FDA-2007-D-0369-0572 FDA None FDA-2007-D-0369 Draft Guidance on Leuprolide Acetate; Revised Guidance; PSG_021088 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:32Z   1 0 0900006484e387dc
FDA-2007-D-0369-0613 FDA None FDA-2007-D-0369 Draft Guidance on Lactitol; New Guidance; PSG_211281 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:38Z   1 0 0900006484e38839
FDA-2007-D-0369-0606 FDA None FDA-2007-D-0369 Draft Guidance on Metoclopramide Hydrochloride; Revised Guidance; PSG_022246 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:37Z   1 0 0900006484e3882b
FDA-2007-D-0369-0603 FDA None FDA-2007-D-0369 Draft Guidance on Desloratadine; Revised Guidance; PSG_021312 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:37Z   1 0 0900006484e38825
FDA-2007-D-0369-0615 FDA None FDA-2007-D-0369 Draft Guidance on Cenobamate; New Guidance; PSG_212839 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:39Z   1 0 0900006484e3883d
FDA-2007-D-0369-0591 FDA None FDA-2007-D-0369 Draft Guidance on Riluzole; New Guidance; PSG_209080 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:35Z   1 0 0900006484e38802
FDA-2007-D-0369-0578 FDA None FDA-2007-D-0369 Draft Guidance on Dicyclomine Hydrochloride; New Guidance; PSG_007409-Tab Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:33Z   1 0 0900006484e387e8
FDA-2007-D-0369-0580 FDA None FDA-2007-D-0369 Draft Guidance on Ondansetron; Revised Guidance; PSG_020781 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:33Z   1 0 0900006484e387ec
FDA-2007-D-0369-0588 FDA None FDA-2007-D-0369 Draft Guidance on Loratadine; Revised Guidance; PSG_020704 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:35Z   1 0 0900006484e387fc
FDA-2007-D-0369-0589 FDA None FDA-2007-D-0369 Draft Guidance on Minocycline Hydrochloride; New Guidance; PSG_209269 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:35Z   1 0 0900006484e387fe
FDA-2007-D-0369-0569 FDA None FDA-2007-D-0369 Draft Guidance on Artesunate; New Guidance; PSG_213036 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:32Z   1 0 0900006484e37440
FDA-2007-D-0369-0610 FDA None FDA-2007-D-0369 Draft Guidance onColesevelam Hydrochloride; Revised Guidance; PSG_022362 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:38Z   1 0 0900006484e38833
FDA-2007-D-0369-0608 FDA None FDA-2007-D-0369 Draft Guidance on Minocycline Hydrochloride; New Guidance; PSG_213690 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:38Z   1 0 0900006484e3882f
FDA-2007-D-0369-0614 FDA None FDA-2007-D-0369 Draft Guidance on Pemigatinib; New Guidance; PSG_213736 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:39Z   1 0 0900006484e3883b
FDA-2007-D-0369-0594 FDA None FDA-2007-D-0369 Draft Guidance on Bempedoic Acid; New Guidance; PSG_211616 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:35Z   1 0 0900006484e38808
FDA-2007-D-0369-0600 FDA None FDA-2007-D-0369 Draft Guidance on Cetirizine Hydrochloride; Revised Guidance; PSG_022578 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:36Z   1 0 0900006484e3881f
FDA-2007-D-0369-0590 FDA None FDA-2007-D-0369 Draft Guidance on Olanzapine; Revised Guidance; PSG_021086 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:35Z   1 0 0900006484e38800
FDA-2007-D-0369-0597 FDA None FDA-2007-D-0369 Draft Guidance on Tenapanor Hydrochloride; New Guidance; PSG_211801 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:36Z   1 0 0900006484e38818
FDA-2007-D-0369-0609 FDA None FDA-2007-D-0369 Draft Guidance on Carbidopa; Levodopa; Revised Guidance; PSG_076699 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:38Z   1 0 0900006484e38831
FDA-2007-D-0369-0593 FDA None FDA-2007-D-0369 Draft Guidance on Lansoprazole; Revised Guidance; PSG_021428 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:35Z   1 0 0900006484e38806
FDA-2007-D-0369-0612 FDA None FDA-2007-D-0369 Draft Guidance on Opicapone; New Guidance; PSG_212489 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:38Z   1 0 0900006484e38837
FDA-2007-D-0369-0567 FDA None FDA-2007-D-0369 Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z 2022-01-11T04:59:59Z 2021-12-31T02:00:32Z 2021-24431 0 0 0900006484e37a93
FDA-2007-D-0369-0575 FDA None FDA-2007-D-0369 Draft Guidance on Leuprolide Acetate; Norethindrone Acetate; Revised Guidance; PSG_203696 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:32Z   1 0 0900006484e387e2
FDA-2007-D-0369-0568 FDA None FDA-2007-D-0369 Draft Guidance on Beclomethasone Dipropionate Monohydrate; New Guidance; PSG_019389 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:31Z   1 0 0900006484e3743e
FDA-2007-D-0369-0574 FDA None FDA-2007-D-0369 Draft Guidance on Remimazolam Besylate; New Guidance; PSG_212295 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:32Z   1 0 0900006484e387e0
FDA-2007-D-0369-0582 FDA None FDA-2007-D-0369 Draft Guidance on Sodium Iodide I-131; New Guidance; PSG_016517 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:34Z   1 0 0900006484e387f0
FDA-2007-D-0369-0587 FDA None FDA-2007-D-0369 Draft Guidance on Tucatinib; New Guidance; PSG_213411 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:34Z   1 0 0900006484e387fa
FDA-2007-D-0369-0571 FDA None FDA-2007-D-0369 Draft Guidance on Triamcinolone Acetonide; Revised Guidance; PSG_012041 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:32Z   1 0 0900006484e387da
FDA-2007-D-0369-0573 FDA None FDA-2007-D-0369 Draft Guidance on Ciclesonide; New Guidance; PSG_022004 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:32Z   1 0 0900006484e387de
FDA-2007-D-0369-0576 FDA None FDA-2007-D-0369 Draft Guidance on Donepezil Hydrochloride; Revised Guidance; PSG_021720 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:33Z   1 0 0900006484e387e4
FDA-2007-D-0369-0581 FDA None FDA-2007-D-0369 Draft Guidance on Minocycline Hydrochloride; New Guidance; PSG_212379 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:33Z   1 0 0900006484e387ee
FDA-2007-D-0369-0583 FDA None FDA-2007-D-0369 Draft Guidance on Risperidone; Revised Guidance; PSG_021444 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:34Z   1 0 0900006484e387f2
FDA-2007-D-0369-0595 FDA None FDA-2007-D-0369 Draft Guidance on Glucagon; New Guidance; PSG_212097 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:36Z   1 0 0900006484e38814
FDA-2007-D-0369-0598 FDA None FDA-2007-D-0369 Draft Guidance on Potassium Phosphate, Dibasic; Potassium Phosphate, Monobasic; New Guidance; PSG_212832 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:36Z   1 0 0900006484e3881a
FDA-2007-D-0369-0607 FDA None FDA-2007-D-0369 Draft Guidance on Bempedoic Acid; Ezetimibe; New Guidance; PSG_211617 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:37Z   1 0 0900006484e3882d
FDA-2007-D-0369-0599 FDA None FDA-2007-D-0369 Draft Guidance on Diclofenac Potassium; New Guidance; PSG_020142 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:36Z   1 0 0900006484e3881c
FDA-2007-D-0369-0601 FDA None FDA-2007-D-0369 Draft Guidance on Colesevelam Hydrochloride; New Guidance; PSG_210895 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:37Z   1 0 0900006484e38821
FDA-2007-D-0369-0602 FDA None FDA-2007-D-0369 Draft Guidance on Clascoterone; New Guidance; PSG_213433 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:37Z   1 0 0900006484e38823
FDA-2007-D-0369-0577 FDA None FDA-2007-D-0369 Draft Guidance on Mirtazapine; Revised Guidance; PSG_021208 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:33Z   1 0 0900006484e387e6
FDA-2007-D-0369-0584 FDA None FDA-2007-D-0369 Draft Guidance on Potassium Phosphate, Dibasic; Potassium Phosphate, Monobasic; New Guidance; PSG_212121 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:34Z   1 0 0900006484e387f4
FDA-2007-D-0369-0596 FDA None FDA-2007-D-0369 Draft Guidance on Lemborexant; New Guidance; PSG_212028 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:36Z   1 0 0900006484e38816
FDA-2007-D-0369-0604 FDA None FDA-2007-D-0369 Draft Guidance on Draft Guidance on Lurbinectedin; New Guidance; PSG_213702 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:37Z   1 0 0900006484e38827
FDA-2007-D-0369-0605 FDA None FDA-2007-D-0369 Draft Guidance on Rimegepant Sulfate; New Guidance; PSG_212728 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:37Z   1 0 0900006484e38829
FDA-2007-D-0369-0611 FDA None FDA-2007-D-0369 Draft Guidance on Zolmitriptan; Revised Guidance; PSG_021231 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:38Z   1 0 0900006484e38835
FDA-2007-D-0369-0592 FDA None FDA-2007-D-0369 Draft Guidance on Rizatriptan Benzoate; Revised Guidance; PSG_020865 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:35Z   1 0 0900006484e38804
FDA-2007-D-0369-0570 FDA None FDA-2007-D-0369 Draft Guidance on Aripiprazole; Revised Guidance; PSG_021729 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:32Z   1 0 0900006484e387d8
FDA-2007-D-0369-0579 FDA None FDA-2007-D-0369 Draft Guidance on Methylphenidate; Revised Guidance; PSG_205489 Other Guidance 2021-11-09T05:00:00Z 2021 11 2021-11-09T05:00:00Z   2024-11-07T00:33:33Z   1 0 0900006484e387ea
FDA-2007-D-0369-0561 FDA None FDA-2007-D-0369 Product-Specific Guidances for Ferric Oxyhydroxide; Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2021-09-17T04:00:00Z 2021 9 2021-09-17T04:00:00Z 2021-11-17T04:59:59Z 2021-11-18T02:00:11Z 2021-20064 0 0 0900006484d8c141
FDA-2007-D-0369-0560 FDA None FDA-2007-D-0369 Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2021-08-23T04:00:00Z 2021 8 2021-08-23T04:00:00Z 2021-10-23T03:59:59Z 2021-10-21T01:00:31Z 2021-18072 0 0 0900006484c9bafb
FDA-2007-D-0369-0558 FDA None FDA-2007-D-0369 Product-Specific Guidance for Olodaterol Hydrochloride; Tiotropium Bromide; Draft Guidance for Industry; Availability Notice Notice of Availability 2021-07-28T04:00:00Z 2021 7 2021-07-28T04:00:00Z 2021-09-28T03:59:59Z 2021-09-25T01:00:52Z 2021-16046 0 0 0900006484c14747
FDA-2007-D-0369-0554 FDA None FDA-2007-D-0369 Product-Specific Guidance for Cilastatin Sodium; Imipenem; Relebactam; Draft Guidance for Industry; Availability Notice Notice of Availability 2021-07-19T04:00:00Z 2021 7 2021-07-19T04:00:00Z 2021-09-18T03:59:59Z 2021-08-05T20:00:36Z 2021-15170 0 0 0900006484c01943
FDA-2007-D-0369-0555 FDA None FDA-2007-D-0369 Draft Guidance on Cilastatin Sodium; Imipenem; Relebactam July 2021 Other Guidance 2021-07-19T04:00:00Z 2021 7 2021-07-19T04:00:00Z   2021-07-30T18:56:04Z   0 0 0900006484c01d82
FDA-2007-D-0369-0550 FDA None FDA-2007-D-0369 Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2021-05-20T04:00:00Z 2021 5 2021-05-20T04:00:00Z 2021-07-20T03:59:59Z 2021-08-11T01:00:51Z 2021-10589 0 0 0900006484b23761
FDA-2007-D-0369-0548 FDA None FDA-2007-D-0369 Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2021-03-29T04:00:00Z 2021 3 2021-03-29T04:00:00Z 2021-05-25T03:59:59Z 2021-03-29T12:28:38Z 2021–06202 0 0 0900006484a84f91
FDA-2007-D-0369-0547 FDA None FDA-2007-D-0369 Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2021-03-25T04:00:00Z 2021 3 2021-03-25T04:00:00Z 2021-05-25T03:59:59Z 2021-05-25T01:00:43Z 2021-06202 0 0 0900006484a7a413

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 1829.379ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API